Moreover, the disruption of myocardial circulation is boosted by the dysfunction of the SARS-CoV-2 receptor (ACE2) on pericytes, which play an important role in maintaining endothelial function.16 thereby leading to common ischemic and/or thrombotic events seen in COVID-19.13 Similarly, ischemic/thrombotic events (17.3%) are the most frequent complication occurring in our study when we consider MI, ACS, CVA, and DVT as a single subgroup. This evidence concerns the gene ACE2 and COVID-19.